Practice Economics

AARP: Retail drug prices rising faster than inflation


 

References

Retail prices for medications used most commonly by Medicare patients rose almost 10% in 2013 – more than six times faster than the rate of inflation, according to an analysis by the AARP Public Policy Institute.

In 2013, “the average annual cost of drug therapy for prescription drugs, based on the AARP combined market basket used in this study, was over $11,000 per year,” according to the report In comparison, the average Social Security benefit was $15,526, the median income for Medicare beneficiaries was $23,500 and the median U.S. household income was $52,250.

©Mathier/thinkstockphotos.com

Price increases for traditional and specialty brand prescription drugs rose faster than generics, eliminating any offset the declines in generic prices might have had.

The report examined drug prices from 2006 to 2013 for a combined market basket of 622 brand name and generic versions of traditional and specialty prescription drugs.

Of the 397 drugs that were on the market for all years, the average retail price increased 81%.

gtwachtman@frontlinemedcom.com

Recommended Reading

Nuanced approach works best for potential ECT patients
MDedge Endocrinology
Dr. Robert Califf confirmed as FDA commissioner
MDedge Endocrinology
AMA’s Stack ‘cautiously optimistic’ about MACRA implementation
MDedge Endocrinology
VIDEO: Beware legal land mines when working with PAs, NPs
MDedge Endocrinology
DTC genomic tests: Some patients dissatisfied with physician interpretation
MDedge Endocrinology
Feds: Major EHR companies will remove interoperability roadblocks
MDedge Endocrinology
Supreme Court: Self-funded insurer does not have to share data
MDedge Endocrinology
HHS to doctors: We hear your health IT woes
MDedge Endocrinology
Expert counsel: Selling a practice during a government investigation
MDedge Endocrinology
CMS extends EHR hardship exemption deadline to July 1
MDedge Endocrinology